Literature DB >> 6337088

Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.

A W Thomson, D K Moon, C L Geczy, D S Nelson.   

Abstract

Cyclosporin A (Cs A) exerted a dose-related inhibitory effect on antigen (ovalbumin, OVA) and phytohaemagglutinin (PHA)-induced transformation of guinea-pig lymph node cells (LNC). Whereas 0.05 micrograms/ml was sufficient to depress these responses markedly, it required 100-fold this concentration of Cs A to inhibit the production of lymphocyte activating factor (LAF) by lipopolysaccharide (LPS) stimulated peritoneal macrophages. Addition of Cs A together with insoluble concanavalin A (iCon A) to LNC cultures resulted in suppressed lymphokine production, as assessed by measurement of migration inhibition factor (MIF), the generation of macrophage procoagulant activity (MPCA) and the release of lymphocyte-derived-macrophage chemotactic factor (LDCF). Cs A also inhibited MIF and procoagulant production by sensitized peritoneal exudate cells in response to antigen, at the same concentrations which blocked lymphocyte transformation. In contrast, Cs A had no direct effect on the migration of peritoneal cells from capillary tubes, or on the responses of macrophages to preformed MIF, the lymphokine inducing MPCA or LDCF. Overnight incubation of macrophages with Cs A did, however, result in mild inhibition of their basal level of procoagulant activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337088      PMCID: PMC1453909     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Increased chemotactic responses of macrophages from BCG-infected mice.

Authors:  M S Meltzer; E E Jones; D A Boetcher
Journal:  Cell Immunol       Date:  1975-05       Impact factor: 4.868

2.  DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS.

Authors:  J R DAVID; S AL-ASKARI; H S LAWRENCE; L THOMAS
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

3.  Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.

Authors:  A D Hess; P J Tutschka; G W Santos
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

4.  Mechanisms of immunosuppression by cyclosporin.

Authors:  P A Keown; G L Essery; C R Stiller; N R Sinclair; R Mullen; R A Ulan
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

5.  Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses.

Authors:  S Alberti; D Boraschi; W Luini; A Tagliabue
Journal:  Int J Immunopharmacol       Date:  1981

6.  Cyclosporin a permits the distinction between specific T and NK activity generated in a human MLC.

Authors:  U Landegren; U Ramstedt; I Axberg; A Orn; H Wigzell
Journal:  Int J Cancer       Date:  1981-12       Impact factor: 7.396

7.  Inhibition of T-cell activity by cyclosporin A.

Authors:  L Andrus; K J Lafferty
Journal:  Scand J Immunol       Date:  1981-05       Impact factor: 3.487

Review 8.  Immunosuppression with cyclosporin A: a review.

Authors:  C J Green
Journal:  Diagn Histopathol       Date:  1981 Apr-Jun

9.  Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics.

Authors:  I F Hutchinson; C A Shadur; J S Duarte; T B Strom; N L Tilney
Journal:  Transplantation       Date:  1981-09       Impact factor: 4.939

10.  The modulation of lymphocyte functions by molecules secreted by macrophages. I. Description and partial biochemical analysis.

Authors:  J Calderon; J M Kiely; J L Lefko; E R Unanue
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  35 in total

1.  Intubation practice on cadavers should stop.

Authors:  Alison Tonks
Journal:  BMJ       Date:  1992-08-08

2.  Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages.

Authors:  M D Chiara; F Bedoya; F Sobrino
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

3.  Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.

Authors:  K Ahmed; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.

Authors:  C Bogdan; H Streck; M Röllinghoff; W Solbach
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

5.  Modulation of the inhibition of respiratory burst in mouse macrophages by cyclosporin A: effect of in vivo treatment, glucocorticoids and the state of activation of cells.

Authors:  M D Chiara; F Sobrino
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

6.  The comparative effects of cyclosporin A and 16,16 dimethyl prostaglandin E2 on the allogeneic induction of monocyte/macrophage procoagulant activity and the cytokines macrophage procoagulant inducing factor and interleukin-2.

Authors:  S W Chung; P C Kim; I H Koh; L S Fung; E H Cole; Z Cohen; G A Levy
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

7.  Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeks.

Authors:  P H Whiting; J G Simpson; R J Davidson; A W Thomson
Journal:  Br J Exp Pathol       Date:  1983-08

8.  In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus.

Authors:  E Roilides; T Robinson; T Sein; P A Pizzo; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

9.  Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.

Authors:  A W Thomson; D K Moon; Y Inoue; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

10.  EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A.

Authors:  J Liversidge; A W Thomson; H F Sewell; J V Forrester
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.